Quote this publication Share Print

Laboratory examinations to test for Epstein-Barr virus as part of post-transplant lymphoproliferative disorder

-
Health technology assessment - Posted on Nov 20 2015

The aim of this work is to assess the clinical utility of measuring the Epstein-Barr virus (EBV) viral load through real-time genetic amplification (PCR) and testing for serum anti-EBV antibodies as part of post-transplant lymphoproliferative disorder (PTLD), with a view to their inclusion in the list of Procedures in Laboratory Medicine reimbursed by the National Health Insurance system in France

Contact Us

Évaluation des actes professionnels

See also